Exclusive Interview with Dr. Guy Miller, CEO of Edison Pharma.
Is there hope for a cure for Mitochondrial Disease? Perhaps the answer is closer than we thought.
On July 15, 2008 Edison Pharma and partner Penwest Pharmaceuticals announced that A0001, an “improved” variant of Coenzyme Q10 (CoQ10), has entered Phase 1 clinical development with healthy volunteers. Edison predicts trials in patients with inherited mitochondrial disease will begin in 2009.
Join us this month to learn more about the challenges facing kids and adults with Mito when it comes to nutrition. What are the...
A conversation with the public policy team for the National Organization for Rare Disorders (NORD). Topics of discussion will include: Current federal and state...
How can you prepare your child for independence? Transition to independence is challenging and important for all kids, but helping your child make good...